NCT02134431View on ClinicalTrials.gov

Relationship of Tenofovir With HIV-1 Suppression in ex Vivo Tissue in Adolescents

CompletedOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Human Immunodeficiency Virus
Interventions
DEVICE

flexible sigmoidoscopy or colonoscopy with biopsies

Lower endoscopy with biopsies (specifically either colonoscopy or flexible sigmoidoscopy) in both HIV-positive subjects already on oral tenofovir , as well as HIV negative subjects. Biopsies will be taken to laboratory for quantification of HIV-1 and drug levels of tenofovir.

Trial Locations (1)

90095

UCLA Clinical and Translational Research Center (CTRC), Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT02134431 - Relationship of Tenofovir With HIV-1 Suppression in ex Vivo Tissue in Adolescents | Biotech Hunter | Biotech Hunter